posted on 2023-02-16, 03:44authored byKJ Goodall, ML Finch-Edmondson, J van Vuuren, GC Yeoh, IE Gentle, JE Vince, PG Ekert, David VauxDavid Vaux, BA Callus
<p>Apoptosis mediated by Bax or Bak is usually thought to be triggered by BH3-only members of the Bcl-2 protein family. BH3-only proteins can directly bind to and activate Bax or Bak, or indirectly activate them by binding to anti-apoptotic Bcl-2 family members, thereby relieving their inhibition of Bax and Bak. Here we describe a third way of activation of Bax/Bak dependent apoptosis that does not require triggering by multiple BH3-only proteins. In factor dependent myeloid (FDM) cell lines, cycloheximide induced apoptosis by a Bax/Bak dependent mechanism, because Bax-/- Bak-/- lines were profoundly resistant, whereas FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Addition of cycloheximide led to the rapid loss of Mcl-1 but did not affect the expression of other Bcl-2 family proteins. In support of these findings, similar results were observed by treating FDM cells with the CDK inhibitor, roscovitine. Roscovitine reduced Mcl-1 abundance and caused Bax/Bak dependent cell death, yet FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Therefore Bax/Bak dependent apoptosis can be regulated by the abundance of anti-apoptotic Bcl-2 family members such as Mcl-1, independently of several known BH3-only proteins.</p>
Funding
This work was supported by an Association of International Cancer Research project grant (09-0084) and Cancer Council of WA project grants (1010749 and 1067515) and fellowship to BAC, and National Health and Medical Research Council (Canberra, Australia) Project grant (384404), fellowship (1016701), and Program Grant (461221) to DLV, and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS.